Anti-PGM3 antibodies are used in the immunodetection of the protein phosphoglucomutase 3. In humans, the canonical protein has a reported length of 542 amino acid residues and a mass of 59.9 kDa. Up to 3 different isoforms have been reported for this protein. It is notably expressed in many tissues, such as the cerebellum and duodenum. A member of the Phosphohexose mutase protein family, PGM3 is known to catalyze the conversion of GlcNAc-6-P into GlcNAc-1-P during the synthesis of uridine diphosphate/UDP-GlcNAc, a sugar nucleotide critical to multiple glycosylation pathways including protein N- and O-glycosylation. Synonyms for this target antigen include IMD23, PAGM, phosphoacetylglucosamine mutase, N-acetylglucosamine-phosphate mutase 1, acetylglucosamine phosphomutase, and AGM1. PGM3 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of PGM3 antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. Flow Cytometry and Immunohistochemistry are also common applications.